Marché mondial des solutions de surveillance des infections – Tendances et prévisions du secteur jusqu’en 2028

Demande de table des matières Demande de table des matières Parler à un analysteParler à un analyste Acheter maintenantAcheter maintenant Renseignez-vous avant d'acheterRenseignez-vous avant Exemple de rapport gratuitExemple de rapport gratuit

Marché mondial des solutions de surveillance des infections – Tendances et prévisions du secteur jusqu’en 2028

  • Healthcare
  • Upcoming Reports
  • Mar 2021
  • Global
  • 350 Pages
  • Nombre de tableaux : 220
  • Nombre de figures : 60

Marché mondial des systèmes de solutions de surveillance des infections, par produits (logiciels et services), type d'infection (infections du site chirurgical (SSI), infections du flux sanguin (BSI), infections des voies urinaires (UTI), infections du flux sanguin associées aux cathéters centraux (CLABSI), infection des voies urinaires associée aux cathéters (CAUTI) et autres), utilisateur final (hôpitaux, établissements de soins de longue durée, cliniques, centres de chirurgie ambulatoire, instituts universitaires, autres), pays (États-Unis, Canada, Mexique, Allemagne, Italie, Royaume-Uni, France, Espagne, Pays-Bas, Belgique, Suisse, Turquie, Russie, reste de l'Europe, Japon, Chine, Inde, Corée du Sud, Australie, Singapour, Malaisie, Thaïlande, Indonésie, Philippines, reste de l'Asie-Pacifique, Brésil, Argentine, reste de l'Amérique du Sud, Afrique du Sud, Arabie saoudite, Émirats arabes unis, Égypte, Israël, reste du Moyen-Orient et de l'Afrique) Tendances et prévisions de l'industrie jusqu'en 2028

Marché des systèmes de solutions de surveillance des infectionsAnalyse et perspectives du marché : Marché mondial des systèmes de solutions de surveillance des infections

Le marché des systèmes de solutions de surveillance des infections devrait connaître une croissance de 13,3 % au cours de la période de prévision de 2021 à 2028. Le rapport de recherche sur le marché des systèmes de solutions de surveillance des infections de Data Bridge fournit une analyse et des informations sur les différents facteurs qui devraient prévaloir tout au long de la période de prévision tout en fournissant leurs impacts sur la croissance du marché. L'augmentation de la prévalence des infections associées aux soins de santé (IAS) accélère la croissance du marché des systèmes de solutions de surveillance des infections.

Les systèmes de surveillance des infections désignent le type de systèmes utilisés pour surveiller et gérer en continu les données relatives aux infections associées aux soins de santé (IAS) à des fins d'évaluation de la santé publique. On dit que la détection précoce d'une maladie garantit une mise en œuvre appropriée des mesures préventives.

L'augmentation de la résistance des microbes aux antibiotiques et l'adoption élevée de l'automatisation dans les établissements de santé sont les principaux facteurs à l'origine de la croissance du marché des systèmes de solutions de surveillance des infections. L'augmentation des incidences des infections nosocomiales en milieu clinique, notamment les infections des voies urinaires, entre autres infections du site chirurgical, et le manque d'assainissement accélèrent la croissance du marché des systèmes de solutions de surveillance des infections. L'augmentation de la tendance à l'automédication, la capacité accrue des systèmes informatiques à effectuer des traitements analytiques et le non-respect des médicaments prescrits influencent davantage le marché des systèmes de solutions de surveillance des infections. En outre, les initiatives gouvernementales sous forme de politiques, l'augmentation des dépenses de santé, l'augmentation du nombre d'interventions chirurgicales et les activités de recherche et développement affectent positivement le marché des systèmes de solutions de surveillance des infections. En outre, l'intégration des logiciels basés sur le cloud et des économies émergentes étend les opportunités rentables aux acteurs du marché des systèmes de solutions de surveillance des infections au cours de la période de prévision de 2021 à 2028. 

D'autre part, le coût élevé associé aux logiciels, la réticence des professionnels de la santé à adopter des outils de santé avancés et le manque de professionnels de l'informatique qualifiés pour opérer sont les facteurs qui devraient entraver la croissance du marché des systèmes de solutions de surveillance des infections. L'augmentation de la demande de solutions Web et de plateformes mobiles et la préférence des consommateurs pour l'automatisation dans les établissements de santé devraient remettre en cause le marché des systèmes de solutions de surveillance des infections au cours de la période de prévision 2021-2028.

Ce rapport sur le marché des systèmes de solutions de surveillance des infections fournit des détails sur les nouveaux développements récents, les réglementations commerciales, l'analyse des importations et des exportations, l'analyse de la production, l'optimisation de la chaîne de valeur, la part de marché, l'impact des acteurs du marché national et localisé, les opportunités d'analyse en termes de poches de revenus émergentes, les changements dans la réglementation du marché, l'analyse stratégique de la croissance du marché, la taille du marché, la croissance du marché des catégories, les niches d'application et la domination, les approbations de produits, les lancements de produits, les expansions géographiques, les innovations technologiques sur le marché. Pour obtenir plus d'informations sur le marché des systèmes de solutions de surveillance des infections, contactez Data Bridge Market Research pour un briefing d'analyste, notre équipe vous aidera à prendre une décision de marché éclairée pour atteindre la croissance du marché. 

Portée et taille du marché des systèmes de solutions de surveillance des infections

Le marché des systèmes de solutions de surveillance des infections est segmenté en fonction des produits, du type d'infection et de l'utilisateur final. La croissance parmi ces segments vous aidera à analyser les segments de croissance faibles dans les industries et fournira aux utilisateurs un aperçu précieux du marché et du marché.

  • Sur la base des produits, le marché des systèmes de solutions de surveillance des infections est segmenté en logiciels et services.
  • Sur la base du type d'infection, le marché des systèmes de solutions de surveillance des infections est segmenté en infections du site chirurgical (ISO), infections du sang (BSI), infections des voies urinaires (UTI), infections du sang associées aux lignes centrales (CLABSI), infections des voies urinaires associées au cathéter (CAUTI) et autres.
  • Sur la base de l'utilisateur final, le marché des systèmes de solutions de surveillance des infections est segmenté en hôpitaux , établissements de soins de longue durée, cliniques, centres de chirurgie ambulatoire , instituts universitaires et autres.

Analyse du marché mondial des systèmes de solutions de surveillance des infections au niveau des pays

Le marché des systèmes de solutions de surveillance des infections est analysé et des informations et tendances sur la taille du marché sont fournies par pays, produits, type d’infection et utilisateur final, comme référencé ci-dessus.      

Les pays couverts dans le rapport sur le marché mondial des systèmes de solutions de surveillance des infections sont les États-Unis, le Canada et le Mexique en Amérique du Nord, l'Allemagne, la France, le Royaume-Uni, les Pays-Bas, la Suisse, la Belgique, la Russie, l'Italie, l'Espagne, la Turquie, le reste de l'Europe en Europe, la Chine, le Japon, l'Inde, la Corée du Sud, Singapour, la Malaisie, l'Australie, la Thaïlande, l'Indonésie, les Philippines, le reste de l'Asie-Pacifique (APAC) en Asie-Pacifique (APAC), l'Arabie saoudite, les Émirats arabes unis, l'Afrique du Sud, l'Égypte, Israël, le reste du Moyen-Orient et de l'Afrique (MEA) en tant que partie du Moyen-Orient et de l'Afrique (MEA), le Brésil, l'Argentine et le reste de l'Amérique du Sud en tant que partie de l'Amérique du Sud.

L'Amérique du Nord domine le marché des systèmes de surveillance des infections en raison de l'initiative gouvernementale et de l'incidence croissante des infections nosocomiales aux États-Unis et au Canada. L'Asie-Pacifique devrait connaître une croissance significative au cours de la période de prévision de 2021 à 2028 en raison de l'amélioration des infrastructures de santé et de l'augmentation du tourisme médical dans la région.

La section pays du rapport sur le marché des systèmes de solutions de surveillance des infections fournit également des facteurs d'impact sur le marché individuel et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que les volumes de consommation, les sites et volumes de production, l'analyse des importations et des exportations, l'analyse des tendances des prix, le coût des matières premières, l'analyse de la chaîne de valeur en aval et en amont sont quelques-uns des principaux indicateurs utilisés pour prévoir le scénario de marché pour chaque pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et des routes commerciales sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.

Croissance de la base installée des infrastructures de santé et pénétration des nouvelles technologies

Le marché des systèmes de solutions de surveillance des infections vous fournit également une analyse détaillée du marché pour chaque pays, la croissance des dépenses de santé pour les équipements en capital, la base installée de différents types de produits pour le marché des systèmes de solutions de surveillance des infections, l'impact de la technologie à l'aide de courbes de vie et les changements dans les scénarios réglementaires des soins de santé et leur impact sur le marché des systèmes de solutions de surveillance des infections. Les données sont disponibles pour la période historique 2011-2019. 

 Analyse du paysage concurrentiel et des parts de marché des systèmes de solutions de surveillance des infections

Le paysage concurrentiel du marché des systèmes de solutions de surveillance des infections fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché des systèmes de solutions de surveillance des infections.

Les principaux acteurs couverts dans le rapport sur le marché des systèmes de solutions de surveillance des infections sont BD, Cerner Corporation, Illumina, Inc., RL Solutions,GOJO Industries, Inc., SC Johnson & Son, Inc., Baxter, Wolters Kluwer, Vigilanz Corporation, IBM Corporation, HyGreen Inc., Premier, Atlas MD, Deb Group Ltd parmi d'autres acteurs nationaux et mondiaux. Les données sur les parts de marché sont disponibles séparément pour le monde, l'Amérique du Nord, l'Europe, l'Asie-Pacifique (APAC), le Moyen-Orient et l'Afrique (MEA) et l'Amérique du Sud. Les analystes de DBMR comprennent les atouts concurrentiels et fournissent une analyse concurrentielle pour chaque concurrent séparément.


SKU-

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

  • Tableau de bord d'analyse de données interactif
  • Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
  • Accès d'analyste de recherche pour la personnalisation et les requêtes
  • Analyse de la concurrence avec tableau de bord interactif
  • Dernières actualités, mises à jour et analyse des tendances
  • Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Demande de démonstration

Table des matières

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 DBMR MARKET POSITION GRID

2.8 DBMR MARKET CHALLENGE MATRIX

2.9 DBMR VENDOR SHARE ANALYSIS

2.1 MULTIVARIATE MODELING

2.11 PRODUCTS LIFELINE CURVE

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 INCREASING NUMBER OF HEALTHCARE-ACQUIRED INFECTIONS (HAIS)

3.1.2 INCREASING HEALTHCARE EXPENDITURE

3.1.3 GOVERNMENT POLICIES FOR PREVENTING HEALTH-ACQUIRED INFECTIONS (HAIS)

3.2 RESTRAINTS

3.2.1 HIGH COST OF SOFTWARE

3.2.2 DEARTH OF SKILLED IT PROFESSIONALS IN THE HEALTHCARE INDUSTRY

3.3 OPPORTUNITIES

3.3.1 CLOUD-BASED SOFTWARE OFFERS SIGNIFICANT GROWTH OPPORTUNITIES

3.3.2 HIGH GROWTH IN DEVELOPING COUNTRIES ACROSS ASIA-PACIFIC AND LATIN AMERICA

3.4 CHALLENGE

3.4.1 DATA SECURITY RISK

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS

6.1 OVERVIEW

6.2 SOFTWARE

6.2.1 WEB BASED

6.2.2 ON-PREMISE

6.3 SERVICES

6.3.1 TRAINING & CONSULTING SERVICES

6.3.2 IMPLEMENTATION SERVICES

6.3.3 PRODUCT SUPPORT & MAINTENANCE SERVICES

7 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE

7.1 OVERVIEW

7.2 SURGICAL SITE INFECTIONS (SSI)

7.3 URINARY TRACT INFECTIONS (UTI)

7.4 BLOOD STREAM INFECTIONS (BSI)

7.5 CENTRAL LINE-ASSOCIATED BLOOD STREAM INFECTIONS (CLABSI)

7.6 CATHETER-ASSOCIATED URINARY TRACT INFECTION (CAUTI)

7.7 OTHERS

8 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER

8.1 OVERVIEW

8.2 HOSPITALS

8.2.1 LARGE HOSPITALS

8.2.2 MEDIUM-SIZED HOSPITALS

8.2.3 SMALL HOSPITALS

8.3 CLINICS

8.4 AMBULATORY SURGICAL CENTERS

8.5 LONG TERM CARE FACILITIES

8.5.1 NURSING HOMES

8.5.2 HOMECARE AGENCIES & SERVICES

8.5.3 ASSISTED LIVING FACILITIES

8.6 ACADEMIC INSTITUTES

8.7 OTHERS

9 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY GEOGRAPHY

9.1 OVERVIEW

9.2 NORTH AMERICA

9.2.1 U.S.

9.2.2 CANADA

9.2.3 MEXICO

9.3 EUROPE

9.3.1 GERMANY

9.3.2 FRANCE

9.3.3 U.K.

9.3.4 ITALY

9.3.5 SPAIN

9.3.6 NETHERLANDS

9.3.7 SWITZERLAND

9.3.8 BELGIUM

9.3.9 RUSSIA

9.3.10 TURKEY

9.3.11 REST OF EUROPE

9.4 ASIA-PACIFIC

9.4.1 CHINA

9.4.2 JAPAN

9.4.3 SOUTH KOREA

9.4.4 INDIA

9.4.5 AUSTRALIA

9.4.6 SINGAPORE

9.4.7 THAILAND

9.4.8 MALAYSIA

9.4.9 INDONESIA

9.4.10 PHILIPPINES

9.4.11 REST OF ASIA-PACIFIC

9.5 SOUTH AMERICA

9.5.1 BRAZIL

9.5.2 REST OF SOUTH AMERICA

9.6 MIDDLE EAST & AFRICA

9.6.1 SOUTH AFRICA

9.6.2 REST OF MIDDLE EAST & AFRICA

10 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, COMPANY LANDSCAPE

10.1 COMPANY SHARE ANALYSIS: GLOBAL

10.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

10.3 COMPANY SHARE ANALYSIS: EUROPE

10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

11 SWOT ANALYSIS

11.1 DATA BRIDGE MARKET RESEARCH ANALYSIS

12 COMPANY PROFILES

12.1 WOLTERS KLUWER

12.1.1 COMPANY SNAPSHOT

12.1.2 REVENUE ANALYSIS

12.1.3 COMPANY SHARE ANALYSIS

12.1.4 PRODUCT PORTFOLIO

12.1.5 RECENT DEVELOPMENTS

12.2 BD

12.2.1 COMPANY SNAPSHOT

12.2.2 REVENUE ANALYSIS

12.2.3 COMPANY SHARE ANALYSIS

12.2.4 PRODUCT PORTFOLIO

12.2.5 RECENT DEVELOPMENT

12.3 ILLUMINA, INC.

12.3.1 COMPANY SNAPSHOT

12.3.2 REVENUE ANALYSIS

12.3.3 COMPANY SHARE ANALYSIS

12.3.4 PRODUCT PORTFOLIO

12.3.5 RECENT DEVELOPMENTS

12.4 CERNER CORPORATION

12.4.1 COMPANY SNAPSHOT

12.4.2 REVENUE ANALYSIS

12.4.3 COMPANY SHARE ANALYSIS

12.4.4 PRODUCT PORTFOLIO

12.4.5 RECENT DEVELOPMENTS

12.5 BAXTER

12.5.1 COMPANY SNAPSHOT

12.5.2 REVENUE ANALYSIS

12.5.3 COMPANY SHARE ANALYSIS

12.5.4 PRODUCT PORTFOLIO

12.5.5 RECENT DEVELOPMENTS

12.6 GOJO INDUSTRIES, INC.

12.6.1 COMPANY SNAPSHOT

12.6.2 PRODUCT PORTFOLIO

12.6.3 RECENT DEVELOPMENT

12.7 IBM CORPORATION

12.7.1 COMPANY SNAPSHOT

12.7.2 REVENUE ANALYSIS

12.7.3 PRODUCT PORTFOLIO

12.7.4 RECENT DEVELOPMENT

12.8 RL SOLUTIONS

12.8.1 COMPANY SNAPSHOT

12.8.2 PRODUCT PORTFOLIO

12.8.3 RECENT DEVELOPMENT

12.9 S. C. JOHNSON & SON, INC.

12.9.1 COMPANY SNAPSHOT

12.9.2 PRODUCT PORTFOLIO

12.9.3 RECENT DEVELOPMENT

12.1 VIGILANZ CORPORATION

12.10.1 COMPANY SNAPSHOT

12.10.2 PRODUCT PORTFOLIO

12.10.3 RECENT DEVELOPMENT

13 CONCLUSION

14 QUESTIONNAIRE

15 RELATED REPORTS

Liste des tableaux

TABLE 1 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 2 GLOBAL SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 3 GLOBAL SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 4 GLOBAL SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 5 GLOBAL SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 6 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 7 GLOBAL SURGICAL SITE INFECTIONS (SSI) IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 8 GLOBAL URINARY TRACT INFECTIONS (UTI) IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 9 GLOBAL BLOOD STREAM INFECTIONS (BSI) IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 10 GLOBAL CENTRAL LINE-ASSOCIATED BLOOD STREAM INFECTIONS (CLABSI) IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 11 GLOBAL CATHETER-ASSOCIATED URINARY TRACT INFECTION (CAUTI) IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 12 GLOBAL OTHERS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 13 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 14 GLOBAL HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 15 GLOBAL HOSPITAL IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 16 GLOBAL CLINICS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 GLOBAL AMBULATORY SURGICAL CENTERS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 18 GLOBAL LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 19 GLOBAL LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 20 GLOBAL ACADEMIC INSTITUTES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 21 GLOBAL OTHERS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 22 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 23 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 24 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 25 NORTH AMERICA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 26 NORTH AMERICA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 27 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 28 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 29 NORTH AMERICA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 30 NORTH AMERICA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 31 U.S. SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 32 U.S. SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 33 U.S. SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 34 U.S. INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 35 U.S. INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 36 U.S. HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 37 U.S. LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 38 CANADA SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 39 CANADA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 40 CANADA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 41 CANADA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 42 CANADA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 43 CANADA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 44 CANADA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 45 MEXICO SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 46 MEXICO SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 47 MEXICO SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 48 MEXICO INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 49 MEXICO INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 50 MEXICO HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 51 MEXICO LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 52 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 53 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 54 EUROPE SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 55 EUROPE SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 56 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 57 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 58 EUROPE HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 59 EUROPE LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 60 GERMANY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 61 GERMANY SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 62 GERMANY SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 63 GERMANY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 64 GERMANY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 65 GERMANY HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 66 GERMANY LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 67 FRANCE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 68 FRANCE SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 69 FRANCE SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 70 FRANCE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 71 FRANCE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 72 FRANCE HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 73 FRANCE LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 74 U.K. INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 75 U.K. SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 76 U.K. SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 77 U.K. INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 78 U.K. INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 79 U.K. HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 80 U.K. LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 81 ITALY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 82 ITALY SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 83 ITALY SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 84 ITALY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 85 ITALY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 86 ITALY HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 87 ITALY LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 88 SPAIN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 89 SPAIN SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 90 SPAIN SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 91 SPAIN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 92 SPAIN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 93 SPAIN HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 94 SPAIN LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 95 NETHERLANDS INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 96 NETHERLANDS SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 97 NETHERLANDS SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 98 NETHERLANDS INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 99 NETHERLANDS INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 100 NETHERLANDS HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 101 NETHERLANDS LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 102 SWITZERLAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 103 SWITZERLAND SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 104 SWITZERLAND SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 105 SWITZERLAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 106 SWITZERLAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 107 SWITZERLAND HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 108 SWITZERLAND LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 109 BELGIUM INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 110 BELGIUM SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 111 BELGIUM SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 112 BELGIUM INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 113 BELGIUM INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 114 BELGIUM HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 115 BELGIUM LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 116 RUSSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 117 RUSSIA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 118 RUSSIA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 119 RUSSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 120 RUSSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 121 RUSSIA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 122 RUSSIA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 123 TURKEY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 124 TURKEY SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 125 TURKEY SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 126 TURKEY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 127 TURKEY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 128 TURKEY HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 129 TURKEY LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 130 REST OF EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 131 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 132 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 133 ASIA-PACIFIC SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 134 ASIA-PACIFIC SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 135 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 136 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 137 ASIA-PACIFIC HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 138 ASIA-PACIFIC LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 139 CHINA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 140 CHINA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 141 CHINA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 142 CHINA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 143 CHINA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 144 CHINA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 145 CHINA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 146 JAPAN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 147 JAPAN SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 148 JAPAN SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 149 JAPAN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 150 JAPAN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 151 JAPAN HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 152 JAPAN LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 153 SOUTH KOREA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 154 SOUTH KOREA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 155 SOUTH KOREA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 156 SOUTH KOREA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 157 SOUTH KOREA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 158 SOUTH KOREA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 159 SOUTH KOREA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 160 INDIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 161 INDIA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 162 INDIA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 163 INDIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 164 INDIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 165 INDIA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 166 INDIA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 167 AUSTRALIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 168 AUSTRALIA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 169 AUSTRALIA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 170 AUSTRALIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 171 AUSTRALIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 172 AUSTRALIA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 173 AUSTRALIA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 174 SINGAPORE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 175 SINGAPORE SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 176 SINGAPORE SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 177 SINGAPORE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 178 SINGAPORE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 179 SINGAPORE HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 180 SINGAPORE LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 181 THAILAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 182 THAILAND SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 183 THAILAND SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 184 THAILAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 185 THAILAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 186 THAILAND HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 187 THAILAND LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 188 MALAYSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 189 MALAYSIA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 190 MALAYSIA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 191 MALAYSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 192 MALAYSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 193 MALAYSIA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 194 MALAYSIA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 195 INDONESIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 196 INDONESIA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 197 INDONESIA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 198 INDONESIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 199 INDONESIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 200 INDONESIA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 201 INDONESIA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 202 PHILIPPINES INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 203 PHILIPPINES SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 204 PHILIPPINES SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 205 PHILIPPINES INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 206 PHILIPPINES INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 207 PHILIPPINES HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 208 PHILIPPINES LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 209 REST OF ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 210 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 211 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 212 SOUTH AMERICA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 213 SOUTH AMERICA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 214 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 215 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 216 SOUTH AMERICA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 217 SOUTH AMERICA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 218 BRAZIL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 219 BRAZIL SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 220 BRAZIL SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 221 BRAZIL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 222 BRAZIL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 223 BRAZIL HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 224 BRAZIL LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 225 REST OF SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 226 MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 227 MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 228 MIDDLE EAST AND AFRICA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 229 MIDDLE EAST AND AFRICA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 230 MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 231 MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 232 MIDDLE EAST AND AFRICA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 233 MIDDLE EAST AND AFRICA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 234 SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 235 SOUTH AFRICA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

TABLE 236 SOUTH AFRICA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)

TABLE 237 SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)

TABLE 238 SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 239 SOUTH AFRICA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 240 SOUTH AFRICA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 241 REST OF MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

Liste des figures

FIGURE 1 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SEGMENTATION

FIGURE 2 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: DATA VALIDATION MODEL

FIGURE 3 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: GLOBAL VS REGIONAL ANALYSIS

FIGURE 5 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: DBMR MARKET POSITION GRID

FIGURE 8 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: THE MARKET CHALLENGE MATRIX

FIGURE 9 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: DBMR VENDOR SHARE ANALYSIS

FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGE OF THE GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET

FIGURE 11 HEALTHCARE EXPENDITURE IN FEW COUNTRIES (2015 & 2016)

FIGURE 12 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SEGMENTATION

FIGURE 13 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE INCREASING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2019 TO 2026

FIGURE 14 INCREASING NUMBER OF HEALTHCARE-ACQUIRED INFECTIONS (HAIS) AND INCREASING HEALTHCARE EXPENDITURE ARE EXPECTED TO DRIVE THE GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026

FIGURE 15 SOFTWARE IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET IN 2019 & 2026

FIGURE 16 NORTH AMERICA IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKETS FOR GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026

FIGURE 17 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS, 2018

FIGURE 18 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY INFECTION TYPE, 2018

FIGURE 19 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY END USER, 2018

FIGURE 20 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SNAPSHOT (2018)

FIGURE 21 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY GEOGRAPHY (2018)

FIGURE 22 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY GEOGRAPHY (2019 & 2026)

FIGURE 23 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY GEOGRAPHY (2018 & 2026)

FIGURE 24 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS (2019-2026)

FIGURE 25 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SNAPSHOT (2018)

FIGURE 26 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018)

FIGURE 27 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2019 & 2026)

FIGURE 28 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018 & 2026)

FIGURE 29 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS (2019-2026)

FIGURE 30 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SNAPSHOT (2018)

FIGURE 31 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018)

FIGURE 32 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2019 & 2026)

FIGURE 33 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018 & 2026)

FIGURE 34 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS (2019-2026)

FIGURE 35 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SNAPSHOT (2018)

FIGURE 36 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018)

FIGURE 37 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2019 & 2026)

FIGURE 38 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018 & 2026)

FIGURE 39 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS (2019-2026)

FIGURE 40 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SNAPSHOT (2018)

FIGURE 41 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018)

FIGURE 42 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2019 & 2026)

FIGURE 43 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018 & 2026)

FIGURE 44 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS (2019-2026)

FIGURE 45 MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SNAPSHOT (2018)

FIGURE 46 MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018)

FIGURE 47 MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2019 & 2026)

FIGURE 48 MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018 & 2026)

FIGURE 49 MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS (2019-2026)

FIGURE 50 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: COMPANY SHARE 2018 (%)

FIGURE 51 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: COMPANY SHARE 2018 (%)

FIGURE 52 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: COMPANY SHARE 2018 (%)

FIGURE 53 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: COMPANY SHARE 2018 (%)

Voir les informations détaillées Right Arrow

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.